Conference abstract · 7 Jun 2017
Conference abstractPublished 13 Jul 2015
Efflux inhibition during tuberculosis treatment
Johns Hopkins University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Drug resistance during tuberculosis treatment is a major health concern today in the developing countries. One of the mechanisms contributing to the resistance is the efflux of the tuberculosis drugs out of the cell through a variety of pumps. Efflux pump inhibitors such as verapamil may help overcome this tolerance and resistance mechanism and enhance the activity of tuberculosis drugs. Verapamil is an FDA approved drug used to treat heart disease and hypertension. We have recently found that adding verapamil to standard chemotherapy reduced the time required to successful treatment from standard six months to four months, but also significantly decreased the risk of relapse. Another drug that has been recently approved by FDA for tuberculosis treatment is bedaquiline, also known as TMC-207. We found that co-administration of verapamil with sub-inhibitory doses of bedaquiline gave the same bactericidal effect in mice as full bedaquiline dose. In addition to, we also found that adding verapamil to bedaquiline monotherapy protected from development of resistant mutants in vivo. Thus, use of verapamil with bedaquiline may enable use of lower doses of bedaquiline, thereby reducing its dose-related toxicities in tuberculosis patients.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 30 Apr 2015
Miracle Remedy: Inhibition of Bacterial Efflux Pumps by Natural Products
Conference abstract · 2015
Synthetic analogues of pyridine-N-oxide disulfides from Allium stipitatum demonstrate potent antitubercular activities and inhibit mycobacterial drug efflux pumps
Review article · 2016
Efflux Pump Mediated Second-Line Tuberculosis Drug Resistance
Mini review · 28 Feb 2023
Mini Review on Multitudinous Surgeons in the Treatment of Renal Tuberculosis
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectInfectious Diseases
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Shashank Gupta”
